Please check your internet connection and try again.
# Ecospirin Enteric-Coated
## Overview
Ecospirin Enteric-Coated is a brand name for Aspirin, a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. The enteric coating is designed to prevent gastric irritation by delaying the dissolution of the tablet until it reaches the more alkaline environment of the small intestine.
## Primary Indications
* Pain relief (mild to moderate)
* Fever reduction
* Inflammation reduction
* Prophylaxis of cardiovascular events (e.g., myocardial infarction, stroke) in certain patient populations.
## Adult Dosing
* **Analgesic/Antipyretic/Anti-inflammatory:** 325 mg to 650 mg orally every 4 to 6 hours as needed. Maximum daily dose typically 4000 mg.
* **Cardiovascular Prophylaxis (e.g., secondary prevention of MI/stroke):** 75 mg to 325 mg orally once daily. Specific dose depends on indication and physician guidance. Lower doses (e.g., 81 mg) are common for primary prevention in select individuals.
## Pediatric Dosing
Aspirin is generally **not recommended** for children and teenagers with viral infections (e.g., influenza, chickenpox) due to the risk of Reye's syndrome, a rare but serious condition. Specific pediatric dosing for other indications is limited and should be guided by expert consensus or specific product labeling under strict medical supervision.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution. Dose adjustments may be necessary, but specific guidelines are not well-established. Monitor for increased adverse effects.
* **Renal Impairment:** Use with caution. Dose adjustments may be necessary, particularly in severe impairment. Monitor for increased risk of renal toxicity.
* **Elderly:** Increased risk of gastrointestinal bleeding and other adverse effects. Consider lower doses and shorter durations.
## Contraindications
* Known hypersensitivity to aspirin, salicylates, or NSAIDs.
* Asthma, urticaria, or allergic-type reactions to aspirin or other NSAIDs.
* Active gastrointestinal bleeding or peptic ulcer disease.
* Bleeding disorders.
* Children and teenagers with viral infections (risk of Reye's syndrome).
* Severe hepatic or renal impairment.
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, heartburn, occult bleeding, ulcers, perforation, and bleeding. The enteric coating may reduce but does not eliminate this risk.
* **Hematologic:** Increased bleeding time, bruising, epistaxis.
* **Hypersensitivity:** Bronchospasm, rash, urticaria, angioedema.
* **Renal:** Acute kidney injury, interstitial nephritis.
* **Hepatic:** Hepatotoxicity (rare).
* **Other:** Tinnitus, dizziness, headache.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of gastrointestinal toxicity.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** Reduced antihypertensive effect; increased risk of renal impairment.
* **Methotrexate:** Increased methotrexate toxicity.
* **Sulfonylureas:** Increased hypoglycemic effect.
* **Uricosuric agents (e.g., probenecid):** Reduced efficacy of uricosuric agents.
* **Alcohol:** Increased risk of gastrointestinal bleeding.
## Monitoring
* **Gastrointestinal Symptoms:** Assess for signs of dyspepsia, pain, or bleeding.
* **Bleeding:** Monitor for bruising, epistaxis, hematuria, melena, or hematemesis.
* **Renal Function:** Particularly in patients with pre-existing renal disease or those on concomitant nephrotoxic agents.
* **Hepatic Function:** In patients with underlying liver disease or those on long-term therapy.
* **Tinnitus:** Can be an early sign of salicylate toxicity.
## Clinical Pearls
* The enteric coating does not prevent systemic absorption and associated risks like bleeding or tinnitus.
* For acute pain or fever, immediate-release aspirin formulations may provide faster relief.
* For cardiovascular prophylaxis, adherence to the prescribed daily dose is crucial.
* Patients should be advised to avoid alcohol while taking aspirin to minimize gastrointestinal bleeding risk.
* Discontinue aspirin at least 5-7 days prior to elective surgery, as directed by the surgeon.
***
**Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider for any questions regarding your medical condition or treatment. Please refer to the most current prescribing information for the specific product being used.
